BIRB 796 has Distinctive Anti-inflammatory Effects on Different Cell Types

The pro-inflammatory cytokines tumor necrosis factor-α (TNFα) and interleukin (IL)-1β are crucial mediators involved in chronic inflammatory diseases. Inflammatory signal pathways regulate inflammatory cytokine expression-mediated by p38 mitogen activated protein kinase (p38MAPK). Therefore, conside...

Full description

Saved in:
Bibliographic Details
Published in:Immune network 2013, 13(6), , pp.283-288
Main Authors: Ryoo, Soyoon, Choi, Jida, Kim, Jaemyung, Bae, Suyoung, Hong, Jaewoo, Jo, Seunghyun, Kim, Soohyun, Lee, Youngmin
Format: Article
Language:English
Subjects:
Original
면역학
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3043-67187effba939e76d9d28bbb00cac158b9a1bc0eec14ebab32c7c7ebfea3cbd03
cites cdi_FETCH-LOGICAL-c3043-67187effba939e76d9d28bbb00cac158b9a1bc0eec14ebab32c7c7ebfea3cbd03
container_end_page 288
container_issue 6
container_start_page 283
container_title Immune network
container_volume 13
creator Ryoo, Soyoon
Choi, Jida
Kim, Jaemyung
Bae, Suyoung
Hong, Jaewoo
Jo, Seunghyun
Kim, Soohyun
Lee, Youngmin
description The pro-inflammatory cytokines tumor necrosis factor-α (TNFα) and interleukin (IL)-1β are crucial mediators involved in chronic inflammatory diseases. Inflammatory signal pathways regulate inflammatory cytokine expression-mediated by p38 mitogen activated protein kinase (p38MAPK). Therefore, considerable attention has been given to p38MAPK as a target molecule for the development of a novel anti-inflammatory therapeutics. BIRB 796, one of p38MAPK inhibitor, is a candidate of therapeutic drug for chronic inflammatory diseases. In this study, we investigated the effect of BIRB 796 on inflammatory cytokine productions by lipopolysaccharide (LPS) in different immune cell types. BIRB 796 reduced LPS-mediated IL-8 production in THP-1 cells but not in Raw 264.7 cells. Further analysis of signal molecules by western blot revealed that BIRB 796 sufficiently suppressed LPS-mediated phosphorylation of p38MAPK in both cell types whereas it failed to block inhibitor of kappa B (I-κB) degradation in Raw 264.7 cells. Taken together, these results suggest that the anti-inflammatory function of BIRB 796 depends on cell types.
doi_str_mv 10.4110/in.2013.13.6.283
format article
fullrecord <record><control><sourceid>nurimedia_nrf_k</sourceid><recordid>TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_230173</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><nurid>NODE06395154</nurid><sourcerecordid>NODE06395154</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3043-67187effba939e76d9d28bbb00cac158b9a1bc0eec14ebab32c7c7ebfea3cbd03</originalsourceid><addsrcrecordid>eNpVkctvEzEQxi0EoqFw54T2gsRlg1_rxwUpTUMbVFGpCmfL9s5S011vam8q5b_HbUoAaaQZaX7fPPQh9J7gOScEfw5xTjFh8xJiThV7gWYUa1oLoZqXaEYarWoqqD5Bb3L-hbHgTDav0QnlTDWayxn6dra-OaukFtWtzdV5yFOIfgoPUC3iFOoQu94Og53GtK9WXQd-ytUYC1jqBHGqltD31Wa_hfwWvepsn-Hdcz5FP76uNsvL-ur6Yr1cXNWeYc5qIYmS0HXOaqZBila3VDnnMPbWk0Y5bYnzGMATDs46Rr30ElwHlnnXYnaKPh3mxtSZOx_MaMNT_jmau2QWN5u1oQwTyQr65YBud26A1peDk-3NNoXBpv2T8P9ODLdlzINhSjZSyb-7tmm830GezBCyLy_bCOMuG8I1lpQqrguKD6hPY84JuuMags2jWyZE8-iWKSFMcatIPvx73lHwx54CfHx-dVda0AZ7ZL5fn6-wYLohDWe_AQ0BnZs</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1490722849</pqid></control><display><type>article</type><title>BIRB 796 has Distinctive Anti-inflammatory Effects on Different Cell Types</title><source>Open Access: PubMed Central</source><creator>Ryoo, Soyoon ; Choi, Jida ; Kim, Jaemyung ; Bae, Suyoung ; Hong, Jaewoo ; Jo, Seunghyun ; Kim, Soohyun ; Lee, Youngmin</creator><creatorcontrib>Ryoo, Soyoon ; Choi, Jida ; Kim, Jaemyung ; Bae, Suyoung ; Hong, Jaewoo ; Jo, Seunghyun ; Kim, Soohyun ; Lee, Youngmin</creatorcontrib><description>The pro-inflammatory cytokines tumor necrosis factor-α (TNFα) and interleukin (IL)-1β are crucial mediators involved in chronic inflammatory diseases. Inflammatory signal pathways regulate inflammatory cytokine expression-mediated by p38 mitogen activated protein kinase (p38MAPK). Therefore, considerable attention has been given to p38MAPK as a target molecule for the development of a novel anti-inflammatory therapeutics. BIRB 796, one of p38MAPK inhibitor, is a candidate of therapeutic drug for chronic inflammatory diseases. In this study, we investigated the effect of BIRB 796 on inflammatory cytokine productions by lipopolysaccharide (LPS) in different immune cell types. BIRB 796 reduced LPS-mediated IL-8 production in THP-1 cells but not in Raw 264.7 cells. Further analysis of signal molecules by western blot revealed that BIRB 796 sufficiently suppressed LPS-mediated phosphorylation of p38MAPK in both cell types whereas it failed to block inhibitor of kappa B (I-κB) degradation in Raw 264.7 cells. Taken together, these results suggest that the anti-inflammatory function of BIRB 796 depends on cell types.</description><identifier>ISSN: 1598-2629</identifier><identifier>EISSN: 2092-6685</identifier><identifier>DOI: 10.4110/in.2013.13.6.283</identifier><identifier>PMID: 24385947</identifier><language>eng</language><publisher>Korea (South): 대한면역학회</publisher><subject>Original ; 면역학</subject><ispartof>Immune Network, 2013, 13(6), , pp.283-288</ispartof><rights>Copyright © 2013 The Korean Association of Immunologists 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3043-67187effba939e76d9d28bbb00cac158b9a1bc0eec14ebab32c7c7ebfea3cbd03</citedby><cites>FETCH-LOGICAL-c3043-67187effba939e76d9d28bbb00cac158b9a1bc0eec14ebab32c7c7ebfea3cbd03</cites><orcidid>0000-0002-0322-7935</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875787/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875787/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24385947$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001989557$$DAccess content in National Research Foundation of Korea (NRF)$$Hfree_for_read</backlink></links><search><creatorcontrib>Ryoo, Soyoon</creatorcontrib><creatorcontrib>Choi, Jida</creatorcontrib><creatorcontrib>Kim, Jaemyung</creatorcontrib><creatorcontrib>Bae, Suyoung</creatorcontrib><creatorcontrib>Hong, Jaewoo</creatorcontrib><creatorcontrib>Jo, Seunghyun</creatorcontrib><creatorcontrib>Kim, Soohyun</creatorcontrib><creatorcontrib>Lee, Youngmin</creatorcontrib><title>BIRB 796 has Distinctive Anti-inflammatory Effects on Different Cell Types</title><title>Immune network</title><addtitle>Immune Netw</addtitle><description>The pro-inflammatory cytokines tumor necrosis factor-α (TNFα) and interleukin (IL)-1β are crucial mediators involved in chronic inflammatory diseases. Inflammatory signal pathways regulate inflammatory cytokine expression-mediated by p38 mitogen activated protein kinase (p38MAPK). Therefore, considerable attention has been given to p38MAPK as a target molecule for the development of a novel anti-inflammatory therapeutics. BIRB 796, one of p38MAPK inhibitor, is a candidate of therapeutic drug for chronic inflammatory diseases. In this study, we investigated the effect of BIRB 796 on inflammatory cytokine productions by lipopolysaccharide (LPS) in different immune cell types. BIRB 796 reduced LPS-mediated IL-8 production in THP-1 cells but not in Raw 264.7 cells. Further analysis of signal molecules by western blot revealed that BIRB 796 sufficiently suppressed LPS-mediated phosphorylation of p38MAPK in both cell types whereas it failed to block inhibitor of kappa B (I-κB) degradation in Raw 264.7 cells. Taken together, these results suggest that the anti-inflammatory function of BIRB 796 depends on cell types.</description><subject>Original</subject><subject>면역학</subject><issn>1598-2629</issn><issn>2092-6685</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNpVkctvEzEQxi0EoqFw54T2gsRlg1_rxwUpTUMbVFGpCmfL9s5S011vam8q5b_HbUoAaaQZaX7fPPQh9J7gOScEfw5xTjFh8xJiThV7gWYUa1oLoZqXaEYarWoqqD5Bb3L-hbHgTDav0QnlTDWayxn6dra-OaukFtWtzdV5yFOIfgoPUC3iFOoQu94Og53GtK9WXQd-ytUYC1jqBHGqltD31Wa_hfwWvepsn-Hdcz5FP76uNsvL-ur6Yr1cXNWeYc5qIYmS0HXOaqZBila3VDnnMPbWk0Y5bYnzGMATDs46Rr30ElwHlnnXYnaKPh3mxtSZOx_MaMNT_jmau2QWN5u1oQwTyQr65YBud26A1peDk-3NNoXBpv2T8P9ODLdlzINhSjZSyb-7tmm830GezBCyLy_bCOMuG8I1lpQqrguKD6hPY84JuuMags2jWyZE8-iWKSFMcatIPvx73lHwx54CfHx-dVda0AZ7ZL5fn6-wYLohDWe_AQ0BnZs</recordid><startdate>20131201</startdate><enddate>20131201</enddate><creator>Ryoo, Soyoon</creator><creator>Choi, Jida</creator><creator>Kim, Jaemyung</creator><creator>Bae, Suyoung</creator><creator>Hong, Jaewoo</creator><creator>Jo, Seunghyun</creator><creator>Kim, Soohyun</creator><creator>Lee, Youngmin</creator><general>대한면역학회</general><general>The Korean Association of Immunologists</general><scope>DBRKI</scope><scope>TDB</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ACYCR</scope><orcidid>https://orcid.org/0000-0002-0322-7935</orcidid></search><sort><creationdate>20131201</creationdate><title>BIRB 796 has Distinctive Anti-inflammatory Effects on Different Cell Types</title><author>Ryoo, Soyoon ; Choi, Jida ; Kim, Jaemyung ; Bae, Suyoung ; Hong, Jaewoo ; Jo, Seunghyun ; Kim, Soohyun ; Lee, Youngmin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3043-67187effba939e76d9d28bbb00cac158b9a1bc0eec14ebab32c7c7ebfea3cbd03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Original</topic><topic>면역학</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ryoo, Soyoon</creatorcontrib><creatorcontrib>Choi, Jida</creatorcontrib><creatorcontrib>Kim, Jaemyung</creatorcontrib><creatorcontrib>Bae, Suyoung</creatorcontrib><creatorcontrib>Hong, Jaewoo</creatorcontrib><creatorcontrib>Jo, Seunghyun</creatorcontrib><creatorcontrib>Kim, Soohyun</creatorcontrib><creatorcontrib>Lee, Youngmin</creatorcontrib><collection>DBPIA - 디비피아</collection><collection>Korean Database (DBpia)</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Korean Citation Index</collection><jtitle>Immune network</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ryoo, Soyoon</au><au>Choi, Jida</au><au>Kim, Jaemyung</au><au>Bae, Suyoung</au><au>Hong, Jaewoo</au><au>Jo, Seunghyun</au><au>Kim, Soohyun</au><au>Lee, Youngmin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>BIRB 796 has Distinctive Anti-inflammatory Effects on Different Cell Types</atitle><jtitle>Immune network</jtitle><addtitle>Immune Netw</addtitle><date>2013-12-01</date><risdate>2013</risdate><volume>13</volume><issue>6</issue><spage>283</spage><epage>288</epage><pages>283-288</pages><issn>1598-2629</issn><eissn>2092-6685</eissn><abstract>The pro-inflammatory cytokines tumor necrosis factor-α (TNFα) and interleukin (IL)-1β are crucial mediators involved in chronic inflammatory diseases. Inflammatory signal pathways regulate inflammatory cytokine expression-mediated by p38 mitogen activated protein kinase (p38MAPK). Therefore, considerable attention has been given to p38MAPK as a target molecule for the development of a novel anti-inflammatory therapeutics. BIRB 796, one of p38MAPK inhibitor, is a candidate of therapeutic drug for chronic inflammatory diseases. In this study, we investigated the effect of BIRB 796 on inflammatory cytokine productions by lipopolysaccharide (LPS) in different immune cell types. BIRB 796 reduced LPS-mediated IL-8 production in THP-1 cells but not in Raw 264.7 cells. Further analysis of signal molecules by western blot revealed that BIRB 796 sufficiently suppressed LPS-mediated phosphorylation of p38MAPK in both cell types whereas it failed to block inhibitor of kappa B (I-κB) degradation in Raw 264.7 cells. Taken together, these results suggest that the anti-inflammatory function of BIRB 796 depends on cell types.</abstract><cop>Korea (South)</cop><pub>대한면역학회</pub><pmid>24385947</pmid><doi>10.4110/in.2013.13.6.283</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-0322-7935</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1598-2629
ispartof Immune Network, 2013, 13(6), , pp.283-288
issn 1598-2629
2092-6685
language eng
recordid cdi_nrf_kci_oai_kci_go_kr_ARTI_230173
source Open Access: PubMed Central
subjects Original
면역학
title BIRB 796 has Distinctive Anti-inflammatory Effects on Different Cell Types
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T04%3A42%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-nurimedia_nrf_k&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=BIRB%20796%20has%20Distinctive%20Anti-inflammatory%20Effects%20on%20Different%20Cell%20Types&rft.jtitle=Immune%20network&rft.au=Ryoo,%20Soyoon&rft.date=2013-12-01&rft.volume=13&rft.issue=6&rft.spage=283&rft.epage=288&rft.pages=283-288&rft.issn=1598-2629&rft.eissn=2092-6685&rft_id=info:doi/10.4110/in.2013.13.6.283&rft_dat=%3Cnurimedia_nrf_k%3ENODE06395154%3C/nurimedia_nrf_k%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3043-67187effba939e76d9d28bbb00cac158b9a1bc0eec14ebab32c7c7ebfea3cbd03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1490722849&rft_id=info:pmid/24385947&rft_nurid=NODE06395154&rfr_iscdi=true